Omega Pharma Ltd, Napralief 250mg Gastro-Resistant Tablets recall

Omega Pharma Ltd is recalling specific batches of Napralief 250mg gastro-resistant tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the carton.

Pharmacists are advised to stop supplying the specific batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.

Further information, advice and details of the affected batches can be found on the MHRA website.

Please note the MHRA issued an update for this alert on 24/04/26 as there was an incorrect expiry date for one of the batches. This has now been corrected.